- Home
- AVPT vs AMPH Comparison
AVPT vs AMPH Comparison
Compare AVPT & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVPT
- AMPH
- Stock Information
- Founded
- AVPT 2001
- AMPH 1996
- Country
- AVPT United States
- AMPH United States
- Employees
- AVPT N/A
- AMPH N/A
- Industry
- AVPT Computer Software: Prepackaged Software
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- AVPT Technology
- AMPH Health Care
- Exchange
- AVPT Nasdaq
- AMPH Nasdaq
- Market Cap
- AVPT 2.3B
- AMPH 2.5B
- IPO Year
- AVPT N/A
- AMPH 2014
- Fundamental
- Price
- AVPT $12.47
- AMPH $51.45
- Analyst Decision
- AVPT Buy
- AMPH Buy
- Analyst Count
- AVPT 4
- AMPH 4
- Target Price
- AVPT $12.75
- AMPH $63.00
- AVG Volume (30 Days)
- AVPT 510.6K
- AMPH 268.7K
- Earning Date
- AVPT 11-07-2024
- AMPH 11-06-2024
- Dividend Yield
- AVPT N/A
- AMPH N/A
- EPS Growth
- AVPT N/A
- AMPH 62.07
- EPS
- AVPT N/A
- AMPH 3.15
- Revenue
- AVPT $299,879,000.00
- AMPH $712,891,000.00
- Revenue This Year
- AVPT $21.04
- AMPH $18.04
- Revenue Next Year
- AVPT $17.26
- AMPH $4.41
- P/E Ratio
- AVPT N/A
- AMPH $16.26
- Revenue Growth
- AVPT 19.57
- AMPH 31.80
- 52 Week Low
- AVPT $7.08
- AMPH $36.56
- 52 Week High
- AVPT $12.67
- AMPH $65.92
- Technical
- Relative Strength Index (RSI)
- AVPT 61.51
- AMPH 59.40
- Support Level
- AVPT $11.92
- AMPH $49.38
- Resistance Level
- AVPT $12.18
- AMPH $51.84
- Average True Range (ATR)
- AVPT 0.30
- AMPH 1.25
- MACD
- AVPT -0.00
- AMPH 0.10
- Stochastic Oscillator
- AVPT 79.62
- AMPH 78.90
About AVPT AvePoint Inc.
AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.